
Productos combinados fármaco-dispositivo y el artículo 117
Descubre cómo navegar por el cumplimiento del artículo 117 del MDR para las combinaciones fármaco-dispositivo. Garantiza la correcta aplicación con orientaciones esenciales.
Read more
PhD in Bio Engineering, MSc Food & Biotechnology, MSc King's College London, MBA Open University, RAC (EU & Global), Chartered Manager, RAPS European Board Member · Division Head Regulatory Affairs
Salma Michor is currently Division Head Regulatory Affairs at the QbD Group. She served clients such as Johnson & Johnson, Novartis, Pfizer and CSL Behring. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission.
3 articles

Descubre cómo navegar por el cumplimiento del artículo 117 del MDR para las combinaciones fármaco-dispositivo. Garantiza la correcta aplicación con orientaciones esenciales.
Read more
Build a successful compliance program in pharma by strengthening internal controls and procedures to ensure robust regulatory adherence.
Read more
Discover how to navigate compliance with Article 117 of MDR for drug-device combinations. Ensure correct implementation with essential guidance.
Read moreWe use cookies to enhance your experience
We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.